Avalon BioVentures SPV I, L.P. - Insider Non-Derivative Transactions at Janux Therapeutics, Inc. (JANX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Sep 9, 2024, Avalon BioVentures SPV I, L.P.'s relationship to Janux Therapeutics, Inc. (JANX) is TenPercentOwner, and currently has 9,182 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other JANX insiders.
Data Source: SEC.
Avalon BioVentures SPV I, L.P. - Insider Non-Derivative Transactions of JANX Common Stock
Avalon BioVentures SPV I, L.P. - Insider Non-Derivative Transactions at JANX
Items per page:
0 of 0
Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
---|---|---|---|---|
Sep 10, 2024 | Sell -- (Common Stock) | 2182 | 42.33 | 7000 |
Sep 10, 2024 | M -- (Common Stock) | 994 | 17 | 8077 |
Sep 10, 2024 | M -- (Common Stock) | 414 | 10.73 | 8491 |
Sep 10, 2024 | M -- (Common Stock) | 414 | 13.22 | 8905 |
Sep 10, 2024 | M -- (Common Stock) | 277 | 39.8 | 9182 |
Sep 7, 2024 | Sell -- (Common Stock) | 20991 | 42 | 612682 |
Sep 7, 2024 | Sell -- (Common Stock) | 108365 | 42 | 3162851 |
Sep 7, 2024 | Sell -- (Common Stock) | 110644 | 42 | 3229374 |
Nov 14, 2023 | P -- (Common Stock) | 849854 | 5.87 | 849854 |